Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v3-EN
Language English English
Date Updated 2018-09-27 2018-09-26
Drug Identification Number 02381567 02381567
Brand name ARZERRA ARZERRA
Common or Proper name Arzerra 1000MG VIALS Arzerra 1000MG VIALS
Company Name NOVARTIS PHARMACEUTICALS CANADA INC NOVARTIS PHARMACEUTICALS CANADA INC
Ingredients Ofatumumab Ofatumumab
Strength(s) 1000MG 1000MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 50ML X 1 50ML X 1
ATC code L01XC L01XC
ATC description OTHER ANTINEOPLASTIC AGENTS OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2017-02-28 2017-02-28
Estimated end date
Actual end date 2018-09-26 2018-09-26
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Product will be discontinued. Communication letter to follow. Product will be discontinued. Communication letter to follow.
Health Canada comments